Gimeno F A, Calvo J, Loinaz C, Meneu J C, Pérez B, Gomez R, Jiménez C, Abradelo M, Moreno A, Sesma A, García I, Moreno E
Servicio de Cirugía General, Aparato Digestivo y Trasplante de Organos Abdominales (Prof. E. Moreno González), Hospital Universitario 12 de Octubre, Madrid, Spain.
Transplant Proc. 2005 Nov;37(9):3899-903. doi: 10.1016/j.transproceed.2005.10.085.
Portal vein thrombosis (PVT), which had been considered an absolute contraindication to orthotopic liver transplantation (OLT), is currently considered a risk factor that increases morbi-mortality. The objective of this study was to compare OLT outcomes in patients with vs without PVT.
Between April 1986 and December 2003, a sample of 83 patients with PVT was compared with another sample of 83 patients without PVT among 962 OLT performed in our department.
Both groups were homogeneous in terms of epidemiological variables, surgical technique, immunosuppression, and donor-related variables. There were no differences with respect to graft function during the first week following surgery. Surgical time and anhepatic phase duration was longer in the PVT group, albeit the differences were not significant. PVT patients also required more transfusions; a strong statistical association was observed with respect to blood (P = .12) and plasma (P = .11) transfusions and statistically significant differences regarding platelet transfusions (P = .02). Time on mechanical ventilation and the length of stay in the ICU were longer but not significant among PVT patients. The only statistically significant difference was the incidence of portal rethrombosis (P = .02). With respect to mean and global patient and graft actuarial survivals after 1, 3, 5, and 10 years, we have observed no significant intergroup differences, although both patient (P = .48; NS) and graft (P = .96, NS) survivals were lower among PVT cases.
PVT should not only cease to be considered a contraindication for OLT, but there were no significant differences between the outcomes despite this finding.
门静脉血栓形成(PVT)曾被视为原位肝移植(OLT)的绝对禁忌证,目前则被认为是增加病残率和死亡率的一个危险因素。本研究的目的是比较有和没有PVT的患者的OLT结局。
在1986年4月至2003年12月期间,在我们科室进行的962例OLT中,将83例PVT患者的样本与另外83例无PVT患者的样本进行比较。
两组在流行病学变量、手术技术、免疫抑制和供体相关变量方面具有同质性。术后第一周内移植物功能无差异。PVT组的手术时间和无肝期持续时间较长,尽管差异不显著。PVT患者也需要更多的输血;在血液(P = 0.12)和血浆(P = 0.11)输血方面观察到强统计学关联,在血小板输血方面有统计学显著差异(P = 0.02)。PVT患者的机械通气时间和ICU住院时间较长,但无显著差异。唯一具有统计学显著差异的是门静脉再血栓形成的发生率(P = 0.02)。关于1、3、5和10年后患者和移植物的平均及总体精算生存率,我们未观察到组间有显著差异,尽管PVT病例中的患者(P = 0.48;无显著性差异)和移植物(P = 0.96,无显著性差异)生存率较低。
PVT不仅不应再被视为OLT的禁忌证,而且尽管有这一发现,但结局之间并无显著差异。